文献速递胸部CT

慢性阻塞性肺疾病患者的支气管扩张:基于人工智能的支气管逐渐变细比率CT定量分析

Bronchiectasis in patients with chronic obstructive pulmonary disease: AI-based CT quantification using the bronchial tapering ratio.
PubMed 文献 · Eur Radiol · 2025-08-26

本研究利用人工智能在胸部CT上自动量化支气管逐渐变细比率,计算全肺支气管扩张评分,并在两个前瞻性多中心COPD队列中评估该评分与临床结局的关联。结果显示,支气管扩张评分与全因死亡率和急性加重风险独立相关。

要点

  • AI可基于支气管逐渐变细比率自动量化全肺支气管扩张范围。
  • 支气管扩张评分与COPD患者全因死亡率独立相关。
  • 支气管扩张评分与任何急性加重、重度急性加重及首次急性加重时间相关。

核心结论

  • 在COPD患者中,基于AI的CT支气管逐渐变细比率定量评估的支气管扩张范围与全因死亡率和随时间发生的急性加重风险相关。

研究设计与样本

  • 来自两个前瞻性多中心队列的COPD患者,发现队列361例(平均年龄67岁;97.5%男性),验证队列112例(平均年龄67岁;93.7%男性);在基线CT上使用AI进行全肺气道定量,测量每条支气管的逐渐变细比率。

诊断标准与关键数值

  • 支气管扩张评分基于全肺内支气管逐渐变细异常(内腔逐渐变细比率≥1.1,提示气道扩张)的支气管范围计算。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Although chest CT is the primary tool for evaluating bronchiectasis, accurately measuring its extent poses challenges. This study aimed to automatically quantify bronchiectasis using an artificial intelligence (AI)-based analysis of the bronchial tapering ratio on chest CT and assess its association with clinical outcomes in patients with chronic obstructive pulmonary disease (COPD).

MATERIALS AND METHODS: COPD patients from two prospective multicenter cohorts were included. AI-based airway quantification was performed on baseline CT, measuring the tapering ratio for each bronchus in the whole lung. The bronchiectasis score accounting for the extent of bronchi with abnormal tapering (inner lumen tapering ratio ≥ 1.1, indicating airway dilatation) in the whole lung was calculated. Associations between the bronchiectasis score and all-cause mortality and acute exacerbation (AE) were assessed using multivariable models.

RESULTS: The discovery and validation cohorts included 361 (mean age, 67 years; 97.5% men) and 112 patients (mean age, 67 years; 93.7% men), respectively. In the discovery cohort, 220 (60.9%) had a history of at least one AE and 59 (16.3%) died during follow-up, and 18 (16.1%) died in the validation cohort. Bronchiectasis score was independently associated with increased mortality (discovery: adjusted HR, 1.86 [95% CI: 1.08-3.18]; validation: HR, 5.42 [95% CI: 1.97-14.92]). The score was also associated with risk of any AE, severe AE, and shorter time to first AE (for all, p < 0.05).

CONCLUSIONS: In patients with COPD, the quantified extent of bronchiectasis using AI-based CT quantification of the bronchial tapering ratio was associated with all-cause mortality and the risk of AE over time.

KEY POINTS: Question Can AI-based CT quantification of bronchial tapering reliably assess bronchiectasis relevant to clinical outcomes in patients with COPD? Findings Scores from this AI-based method of automatically quantifying the extent of whole lung bronchiectasis were independently associated with all-cause mortality and risk of AEs in COPD patients. Clinical relevance AI-based bronchiectasis analysis on CT may shift clinical research toward more objective, quantitative assessment methods and support risk stratification and management in COPD, highlighting its potential to enhance clinically relevant imaging evaluation.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park H, Choe J, Lee SM, et al. Bronchiectasis in patients with chronic obstructive pulmonary disease: AI-based CT quantification using the bronchial tapering ratio. Eur Radiol. 2025. PMID: 40858775. doi:10.1007/s00330-025-11969-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。